Search
Descriptor English: Rivastigmine
Descriptor Spanish: Rivastigmina
Descriptor rivastigmina
Scope note: Derivado del carbamato e INHIBIDOR DE LA COLINESTERASA reversible que es selectivo para el SISTEMA NERVIOSO CENTRAL y se utiliza para el tratamiento de la DEMENCIA en la ENFERMEDAD DE ALZHEIMER y ENFERMEDAD DE PARKINSON.
Descriptor Portuguese: Rivastigmina
Descriptor French: Rivastigmine
Entry term(s): (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
713, ENA
713, SDZ ENA
ENA 713
ENA 713, SDZ
ENA-713
ENA713
Exelon
Hydrogen Tartrate, Rivastigmine
Rivastigmine Hydrogen Tartrate
RivastigmineTartrate
SDZ ENA 713
Tartrate, Rivastigmine Hydrogen
Tree number(s): D02.241.081.251.583.899
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068836
Scope note: A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Cholinesterase Inhibitors
Neuroprotective Agents
Registry Number: PKI06M3IW0
CAS Type 1 Name: Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
Public MeSH Note: 2016; RIVASTIGMINE was indexed under PHENYLCARBAMATES 2004-2015; and under CARBAMATES 1992-2004
History Note: 2016 (1992)
DeCS ID: 55888
Unique ID: D000068836
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/09
Revision Date: 2016/05/20
Rivastigmine - Preferred
Concept UI M0196402
Scope note A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Preferred term Rivastigmine
Entry term(s) (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
RivastigmineTartrate - Narrower
Concept UI M0398521
Preferred term RivastigmineTartrate
Entry term(s) Hydrogen Tartrate, Rivastigmine
Rivastigmine Hydrogen Tartrate
Tartrate, Rivastigmine Hydrogen
Exelon - Narrower
Concept UI M0398224
Preferred term Exelon
ENA 713 - Related but not broader or narrower
Concept UI M000613690
Preferred term ENA 713
Entry term(s) 713, ENA
713, SDZ ENA
ENA 713, SDZ
ENA-713
ENA713
SDZ ENA 713



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey